
    
      -  Controlled, randomized trial

        -  RA patients under routine anti-rheumatic care were randomized to receive the treatment
           with or without 400 mg puerarin injection

        -  Assessments were made at entry, 12 and 24 weeks

        -  The overall sample size was assessed before the enrollment

        -  Randomization was performed using concealed random allocation method

        -  The collected data was processed and assessed by two reviewers

        -  All the measurement and analysis procedures concerning CIMT were performed by a single
           ultra sonographer and a single reader, who were blinded to patient profiles and group
           assignment

        -  The reproducibility of the ultrasonographic method was test before the trial
    
  